8-K: Health In Tech Appoints New CEO, Founder Becomes Executive Chairman

Health In Tech, Inc. announced the appointment of Sanjay Shrestha as CEO, succeeding founder Tim Johnson who will transition to Executive Chairman, signaling a new phase of growth and strategic expansion.

Summary

• Health In Tech, Inc. has appointed Sanjay Shrestha as its new Chief Executive Officer, effective October 20, 2026.
• Founder Tim Johnson will transition from CEO to Executive Chairman of the Board, focusing on long-term strategy and innovation.
• This leadership change is intended to accelerate commercial execution, pursue strategic acquisitions, and enhance shareholder value.
• Sanjay Shrestha brings extensive experience in public-company leadership, capital markets, and strategic acquisitions, having previously served as President of Plug Power, Inc.
• The company aims to scale existing businesses, expand adoption of its solutions, and explore strategic partnerships and acquisitions.
• Mr. Shrestha's compensation includes a base salary of $500,000, potentially increasing to $700,000 upon raising $10 million, and eligibility for an annual bonus up to 200% of base salary.
• Significant equity awards are granted to Mr. Shrestha, including a Sign-On Award, Acquisition Award, and Market Capitalization Awards, contingent on performance and stock price thresholds.
• The company is seeking stockholder approval for additional share issuances for certain market capitalization awards at the November 10, 2026 Annual Meeting.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive development, indicating a strategic shift towards experienced leadership for growth and expansion, though the full impact remains to be seen.

Positives

• Appointment of Sanjay Shrestha, an experienced executive with a strong background in public company leadership, capital markets, and strategic acquisitions, to the CEO role.
• Founder Tim Johnson's continued involvement as Executive Chairman will ensure continuity in long-term strategy and innovation.
• Clear delineation of responsibilities between the new CEO and Executive Chairman, aiming to balance operational execution with strategic vision.
• The company is actively pursuing growth through organic expansion, commercial execution, and strategic acquisitions.
• Sanjay Shrestha's compensation package includes a significant base salary and performance-based bonuses, aligning his incentives with company performance.
• Substantial restricted stock awards are granted to the new CEO, incentivizing long-term value creation and alignment with shareholders.
• The company is focused on leveraging its AI-enabled InsurTech platform (HitRix) to transform the health insurance marketplace.

Negatives

• The grant of significant market capitalization awards (MC-2, MC-3, MC-4) totaling 2.5 million shares is contingent on stockholder approval, introducing uncertainty.
• The company's ability to achieve market capitalization thresholds for certain equity awards is subject to market performance and future stock price.
• The Acquisition Award for Mr. Shrestha is contingent on closing a qualifying acquisition by December 31, 2028, with forfeiture if not met.
• The company's ability to regain and maintain compliance with Nasdaq listing requirements is mentioned as a risk.

Risks

• Risks related to the leadership transition, including the ability to successfully integrate new management and retain key personnel.
• Challenges in identifying, negotiating, financing, completing, and integrating acquisitions or other strategic transactions.
• The need to obtain funding for operations and to enhance current systems and expand service offerings.
• The risk of not regaining or maintaining compliance with Nasdaq continued listing requirements.
• Potential cybersecurity incidents or other network disruptions.
• Risks associated with the use of third-party artificial intelligence.
• The need to comply with new or modified laws and regulations, particularly in the insurance services and data privacy sectors.
• The future trading price of the company's common stock.

Future Outlook

The company aims to accelerate organic growth and commercial execution, expand the adoption of its solutions, strengthen distribution and carrier partnerships, and evaluate potential acquisitions and strategic investments to create long-term shareholder value. The leadership transition is expected to drive scalable growth and enhance operational capabilities.

Management Comments

• "As we look ahead, the opportunity is not only to continue innovating, but also to scale our capabilities, expand our reach and unlock the broader potential of what we have built. This leadership transition is a deliberate step toward that next chapter."
• "Sanjay brings a combination of public-company operating experience, capital markets expertise, strategic vision and business development capabilities. Having worked closely with him, I believe his leadership will strengthen our ability to turn opportunities into execution and position Health In Tech for sustainable long-term growth."
• "I am excited to take on the role of CEO at this important stage in the Companys evolution. My immediate focus will be on strengthening execution, scaling our existing businesses, accelerating commercial adoption and building the operational infrastructure needed to support the next phase of growth."
• "Beyond organic expansion, I see opportunities to evaluate strategic acquisitions, partnerships and investments that can complement our platform, broaden our capabilities and enhance our competitive position."

Industry Context

StockSavvy.ai notes that the InsurTech sector is highly competitive and rapidly evolving, with a strong emphasis on AI and data analytics. This leadership change, bringing in an executive with experience in scaling businesses and capital markets, suggests Health In Tech is positioning itself for more aggressive growth and potential consolidation within the industry.

Management Changes

Corporate Governance

Related Party Transactions

• Sanjay Shrestha previously served as an independent director and Strategic Advisor to the Board, receiving compensation for these roles.
• No other direct or indirect material interest in any transaction or proposed transaction required to be disclosed was noted for Mr. Shrestha, other than his prior board service compensation.

Stakeholder Impact

• Shareholders: Potential for increased shareholder value through strategic growth initiatives and experienced leadership, but also contingent on successful execution and potential dilution from equity awards if not fully performance-met.
• Employees: Potential for increased focus on operational execution and growth, with incentives tied to performance. Retention of key personnel is a stated risk.
• Management: Clearer roles and responsibilities, with the new CEO focused on execution and the founder on long-term strategy.

Next Steps

• Sanjay Shrestha to lead the company as CEO, focusing on execution, scaling, and commercial adoption.
• Tim Johnson to focus on long-term strategy, technology innovation, and product development as Executive Chairman.
• The company will evaluate potential acquisitions, strategic investments, and partnerships.
• Stockholders will vote on proposed amendments to the Equity Incentive Plan at the November 10, 2026 Annual Meeting to increase authorized shares.
• The company will continue to develop and evolve its AI-enabled marketplace solutions.

Key Dates

Recommendation

The appointment of an experienced CEO and the clear strategic direction are positive. However, the reliance on future capital raises and stockholder approval for equity grants, coupled with inherent risks in the InsurTech sector and the need for successful integration and execution, warrants a 'hold' recommendation pending further operational and financial developments.

Keywords

CEO Appointment, Leadership Transition, Strategic Expansion, InsurTech, AI Platform, Commercial Execution, Acquisitions, Health Insurance